Inventor · disambiguated record
Michel Gallant
Also filed as: GALLANT MICHEL
28 granted patents·13 pending applications·472 citations·filing 1995–2024
96Inventor score
Files withVERTEX PHARMA12MERCK FROSST CANADA INC8DUBE DANIEL4MERCK FROSST CANADA LTD3BAYLY CHRISTOPHER I2
Top patents by PatentIndex Score
41 records- 0196US5532237AIndole derivatives with affinity for the cannabinoid receptorMERCK FROSST CANADA INC·Filed 1995·Granted Jul 2, 1996·223 cites·5 claims
- 0292US6410563B1Substituted 8-arylquinoline phosphodiesterase-4 inhibitorsMERCK FROSST CANADA INC·Filed 2000·Granted Jun 25, 2002·42 cites·23 claims
- 0388US7622501B2Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitorsMERCK FROSST CANADA INC·Filed 2005·Granted Nov 24, 2009·14 cites·15 claims
- 0485US6242493B1Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatmentMERCK FROSST CANADA INC·Filed 1999·Granted Jun 5, 2001·41 cites·16 claims
- 0584US6211197B1Prostaglandin receptor ligandsMERCK FROSST CANADA INC·Filed 1999·Granted Apr 3, 2001·61 cites·12 claims
- 0675US8637671B2Indole derivatives as CRTH2 receptor antagonistsCOLUCCI JOHN·Filed 2009·Granted Jan 28, 2014·3 cites·10 claims
- 0774US2025179091A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0873US11634447B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2020·Granted Apr 25, 2023·0 cites·20 claims
- 0972US7153968B28-(biaryl)quinoline PDE4 inhibitorsMERCK FROSST CANADA LTD·Filed 2003·Granted Dec 26, 2006·7 cites·23 claims
- 1071US9598454B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2013·Granted Mar 21, 2017·1 cites·17 claims
- 1170US6919353B2Substituted 8-arylquinolune PDE4 inhibitorsMERCK FROSST CANADA INC·Filed 2002·Granted Jul 19, 2005·5 cites·23 claims
- 1269US10669298B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2018·Granted Jun 2, 2020·0 cites·20 claims
- 1369US8063105B2Renin inhibitorsBAYLY CHRISTOPHER I·Filed 2006·Granted Nov 22, 2011·1 cites·8 claims
- 1469US6627656B2Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful thereforeFiled 2001·Granted Sep 30, 2003·5 cites·5 claims
- 1567US10913761B22,7-dibromospiro[fluorene-9,4′-piperidine] compoundsVERTEX PHARMA·Filed 2020·Granted Feb 9, 2021·0 cites·12 claims
- 1666US7482456B28-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitorsMERCK FROSST CANADA·Filed 2004·Granted Jan 27, 2009·3 cites·25 claims
- 1766US5834228AMethod for identifying inhibitors for apopain based upon the crystal structure of the apopain: Ac-DEVD-CHO complexMERCK & CO INC·Filed 1997·Granted Nov 10, 1998·38 cites·8 claims
- 1865US9890176B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2014·Granted Feb 13, 2018·1 cites·22 claims
- 1964US12269831B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Apr 8, 2025·0 cites·41 claims
- 2063US7144896B2Hetero-bridge substituted 8-arylquinoline pde4 inhibitorsMERCK FROSST CANADA LTD·Filed 2003·Granted Dec 5, 2006·2 cites·27 claims
- 2163US5798442APeptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinasesMERCK FROSST CANADA INC·Filed 1995·Granted Aug 25, 1998·25 cites·3 claims
- 2261US2025122218A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2356US12324802B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Jun 10, 2025·0 cites·53 claims
- 2456US9963478B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2016·Granted May 8, 2018·0 cites·32 claims
- 2552US7238706B24-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitorsMERCK FROSST CANADA LTD·Filed 2004·Granted Jul 3, 2007·0 cites·15 claims
- 2651US2025177396A1Polo-like kinase 4 (plk4) inhibitors, pharmaceutical compositions, methods of preparation and uses thereofREPARE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2750US2025026748A1N-(5-substituted-[(1,3,4-thiadiazolyl) or (thiazolyl)])(substituted)carboxamide compounds and use thereof for inhibiting human polymerase thetaREPARE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2848US2008070940A14-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing sameDUBE DANIEL·Filed 2007·Application pending·0 cites
- 2946US8343968B2Case of renin inhibitorsMERCK CANADA INC·Filed 2008·Granted Jan 1, 2013·0 cites·15 claims
- 3046US2007099951A14-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing sameDUBE DANIEL·Filed 2006·Application pending·0 cites
- 3145US7342024B24-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitorsMERCK FROST CANADA LTD·Filed 2003·Granted Mar 11, 2008·0 cites·12 claims
- 3245US2006040981A1Use of phosphodiesterase-4 inhibitors as enhancers of cognitionDUBE DANIEL·Filed 2003·Application pending·0 cites
- 3344US2001031766A1Prostaglandin receptor ligandsMERCK FROSST CANADA INC·Filed 2001·Application pending·0 cites
- 3444US2012046293A1Renin inhibitorsBAYLY CHRISTOPHER I·Filed 2011·Application pending·0 cites
- 3542US8334308B2Renin inhibitorsJUTEAU HELENE·Filed 2008·Granted Dec 18, 2012·0 cites·11 claims
- 3642US8076359B2Renin inhibitorsDUBE DANIEL·Filed 2007·Granted Dec 13, 2011·0 cites·9 claims
- 3742US2013244929A1Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterialsGALLANT MICHEL·Filed 2011·Application pending·0 cites
- 3841US2013261077A1Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 3940US2008242722A1Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular EventsDUFRESNE CLAUDE·Filed 2005·Application pending·0 cites
- 4037US10407414B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2016·Granted Sep 10, 2019·0 cites·19 claims
- 4130US2012035214A1Renin inhibitorsMCKAY DANIEL J·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michel Gallant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →